Form 4 for AGL agilon health, inc.
Accepted 2023-04-19 00:00:00 ET · period of report 2023-04-17 · accession 0001209191-23-024878 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-04-19 | 2023-04-17+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $2.93 | +50.0K | 104.5K | +92% | +$146.3K |
| DM | 2023-04-19 | 2023-04-17+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $27.90 | -50.0K | 80.9K | -38% | -$1.39M |
| DM | 2023-04-19 | 2023-04-17+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $0.00 | -50.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-17 | M | A | 1,851 | $1.00 | 81,394 | D | — | — | (F1) Includes restricted stock units. |
| 2 | Common | Common Stock | 2023-04-17 | M | A | 23,149 | $3.00 | 104,543 | D | — | — | (F1) Includes restricted stock units. |
| 3 | Common | Common Stock | 2023-04-18 | S | D | 25,000 | $28.05 | 79,543 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.64 to $28.255, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F1) Includes restricted stock units. |
| 4 | Common | Common Stock | 2023-04-17 | S | D | 1,400 | $28.54 | 79,543 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $28.46 to $28.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F1) Includes restricted stock units. |
| 5 | Common | Common Stock | 2023-04-18 | M | A | 25,000 | $3.00 | 104,543 | D | — | — | (F1) Includes restricted stock units. |
| 6 | Common | Common Stock | 2023-04-17 | S | D | 23,600 | $27.70 | 80,943 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.42 to $28.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F1) Includes restricted stock units. |
| 7 | Derivative | Options (Right to buy) | 2023-04-18 | M | D | 25,000 | $0.00 | 51,851 | D | $3.00 · — to 2027-04-27 | 25,000 Common Stock | (F7) These options were granted on April 27, 2017, and became fully vested as of September 14, 2021. |
| 8 | Derivative | Options (Right to buy) | 2023-04-17 | M | D | 23,149 | $0.00 | 76,851 | D | $3.00 · — to 2027-04-27 | 23,149 Common Stock | (F7) These options were granted on April 27, 2017, and became fully vested as of September 14, 2021. |
| 9 | Derivative | Options (Right to buy) | 2023-04-17 | M | D | 1,851 | $0.00 | 0 | D | $1.00 · — to 2027-04-27 | 1,851 Common Stock | (F6) These options were granted on April 27, 2017, and became fully vested as of January 12, 2021. |